Wu Hongyi, Guduguntla Arjun, Gyomber Dennis, Niall Owen, Satasivam Prassannah
Department of Surgery, Melbourne Medical School, The University of Melbourne, Northern Health, Melbourne, Victoria, Australia.
Department of Urology, Northern Health, Melbourne, Victoria, Australia.
ANZ J Surg. 2025 Jan-Feb;95(1-2):117-123. doi: 10.1111/ans.19357. Epub 2024 Dec 13.
Surgical risk calculators are not often routinely used in Urology Multidisciplinary Meetings (MDM), and little is known about their impact on clinical decision-making. The aim of this study is to assess the utility of the American College of Surgeons National Surgical Quality Improvement Program (NSQIP) risk calculator for decision-making in the Urology MDM setting, with particular consideration given to decisions about surgical candidacy.
We analysed all adult patients discussed in our Urology MDM with urological conditions whose management plan could potentially include major surgery. During a MDM, a consensus management decision was made prior to the NSQIP score being revealed to blinded team members. Any change in decision after revealing the score was documented, including rationale.
Sixty-three out of 64 eligible cancer cases being discussed at MDM warranted NSQIP scores being revealed to the MDM post initial consensus. 95.2% (n = 60) did not have a change in the MDM management plan after reveal of NSQIP score. The NSQIP score led to a change in the MDM management decision in three cases: two renal cancer cases where management changed to biopsy with view to microwave ablation if positive, and one prostate cancer case, where management changed to recommend against radical prostatectomy.
The NSQIP risk calculator was a useful tool and adjunct in the MDM setting. It served as a safety net where surgical risk was not initially properly estimated by team members, and reinforced decisions where there was concordance between NSQIP score and clinical judgement.
手术风险计算器在泌尿外科多学科会诊(MDM)中并不经常被常规使用,人们对其对临床决策的影响知之甚少。本研究的目的是评估美国外科医师学会国家外科质量改进计划(NSQIP)风险计算器在泌尿外科MDM环境中辅助决策的效用,尤其关注关于手术候选资格的决策。
我们分析了在泌尿外科MDM中讨论的所有患有泌尿系统疾病且治疗计划可能包括大手术的成年患者。在MDM期间,在向不知情的团队成员透露NSQIP评分之前,先达成了共识性的治疗决策。记录在透露评分后决策的任何变化,包括理由。
在MDM中讨论的64例符合条件的癌症病例中,有63例在初步达成共识后需要向MDM透露NSQIP评分。在透露NSQIP评分后,95.2%(n = 60)的患者MDM治疗计划没有改变。NSQIP评分导致MDM治疗决策发生变化的有3例:2例肾癌病例,治疗方案改为活检,若结果为阳性则考虑微波消融;1例前列腺癌病例,治疗方案改为不建议行根治性前列腺切除术。
NSQIP风险计算器在MDM环境中是一个有用的工具和辅助手段。它在团队成员最初未正确评估手术风险时起到了安全网的作用,并且在NSQIP评分与临床判断一致时强化了决策。